• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有低污染和减少细胞摄取特性的混合电荷伪两性离子介孔硅纳米粒子。

Mixed-charge pseudo-zwitterionic mesoporous silica nanoparticles with low-fouling and reduced cell uptake properties.

机构信息

Chemistry in Pharmaceutical Sciences Department, Inorganic and Bioinorganic Chemistry Unit, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital 12 de Octubre i+12, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain.

Chemistry in Pharmaceutical Sciences Department, Inorganic and Bioinorganic Chemistry Unit, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital 12 de Octubre i+12, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain; CIBER Bioengineering, Biomaterials and Nanomedicine, CIBER-BBN, Madrid, Spain.

出版信息

Acta Biomater. 2019 Jan 15;84:317-327. doi: 10.1016/j.actbio.2018.12.012. Epub 2018 Dec 6.

DOI:10.1016/j.actbio.2018.12.012
PMID:30529082
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6718287/
Abstract

The design of drug delivery systems needs to consider biocompatibility and host body recognition for an adequate actuation. In this work, mesoporous silica nanoparticles (MSNs) surfaces were successfully modified with two silane molecules to provide mixed-charge brushes (-NH/-PO) and well evaluated in terms of surface properties, low-fouling capability and cell uptake in comparison to PEGylated MSNs. The modification process consists in the simultaneous direct-grafting of hydrolysable short chain amino (aminopropyl silanetriol, APST) and phosphonate-based (trihydroxy-silyl-propyl-methyl-phosphonate, THSPMP) silane molecules able to provide a pseudo-zwitterionic nature under physiological pH conditions. Results confirmed that both mixed-charge pseudo-zwitterionic MSNs (ZMSN) and PEG-MSN display a significant reduction of serum protein adhesion and macrophages uptake with respect to pristine MSNs. In the case of ZMSNs, this reduction is up to a 70-90% for protein adsorption and c.a. 60% for cellular uptake. This pseudo-zwitterionic modification has been focused on the aim of local treatment of bacterial infections through the synergistic effect between the inherent antimicrobial effect of mixed-charge system and the levofloxacin antibiotic release profile. These findings open promising future expectations for the effective treatment of bacterial infections through the use of mixed-charge pseudo-zwitterionic MSNs furtive to macrophages and with antimicrobial properties. STATEMENT OF SIGNIFICANCE: Herein a novel antimicrobial mixed-charge pseudo-zwitterionic MSNs based system with low-fouling and reduced cell uptake behavior has been developed. This chemical modification has been performed by the simultaneous grafting of short chain organosilanes, containing amino and phosphonate groups, respectively. This nanocarrier has been tested for local infection treatment through the synergy between the antimicrobial effect of mixed-charge brushes and the levofloxacin antibiotic release profile.

摘要

药物输送系统的设计需要考虑生物相容性和宿主身体识别,以实现适当的驱动。在这项工作中,成功地用两种硅烷分子对介孔硅纳米粒子(MSNs)表面进行了修饰,提供了混合电荷刷(-NH/-PO),并从表面性质、低污染能力和细胞摄取等方面与 PEG 化 MSNs 进行了很好的比较。修饰过程包括同时直接接枝可水解短链氨基(氨丙基硅烷三醇,APST)和基于磷酸酯的(三羟基硅基丙基甲基磷酸酯,THSPMP)硅烷分子,在生理 pH 条件下能够提供假两性离子性质。结果证实,与原始 MSNs 相比,两种混合电荷假两性离子 MSNs(ZMSN)和 PEG-MSN 均显著减少了血清蛋白黏附和巨噬细胞摄取。在 ZMSNs 的情况下,这种减少高达蛋白质吸附的 70-90%,细胞摄取的 60%左右。这种假两性离子修饰的目的是通过混合电荷体系固有的抗菌作用和左氧氟沙星抗生素释放特性的协同作用,实现细菌感染的局部治疗。这些发现为通过使用对巨噬细胞具有隐匿性和抗菌特性的混合电荷假两性离子 MSNs 进行有效的细菌感染治疗开辟了广阔的前景。

意义陈述

本文开发了一种具有低污染和减少细胞摄取行为的新型抗菌混合电荷假两性离子 MSNs 基于系统。这种化学修饰是通过同时接枝短链有机硅烷来完成的,分别含有氨基和磷酸酯基团。这种纳米载体已通过混合电荷刷的抗菌作用与左氧氟沙星抗生素释放特性的协同作用,用于局部感染治疗的测试。

相似文献

1
Mixed-charge pseudo-zwitterionic mesoporous silica nanoparticles with low-fouling and reduced cell uptake properties.具有低污染和减少细胞摄取特性的混合电荷伪两性离子介孔硅纳米粒子。
Acta Biomater. 2019 Jan 15;84:317-327. doi: 10.1016/j.actbio.2018.12.012. Epub 2018 Dec 6.
2
Mesoporous silica nanoparticles decorated with polycationic dendrimers for infection treatment.介孔硅纳米粒子用阳离子树状聚合物进行修饰,用于感染治疗。
Acta Biomater. 2018 Mar 1;68:261-271. doi: 10.1016/j.actbio.2017.12.041. Epub 2018 Jan 5.
3
Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.硅醚喜树碱从硫醇-烯点击化学功能化介孔二氧化硅纳米颗粒中的控释。
Acta Biomater. 2017 Mar 15;51:471-478. doi: 10.1016/j.actbio.2017.01.062. Epub 2017 Jan 25.
4
Strontium-releasing mesoporous bioactive glasses with anti-adhesive zwitterionic surface as advanced biomaterials for bone tissue regeneration.锶释放的具有抗粘连两性离子表面的中孔生物活性玻璃作为先进的骨组织再生生物材料。
J Colloid Interface Sci. 2020 Mar 15;563:92-103. doi: 10.1016/j.jcis.2019.12.047. Epub 2019 Dec 14.
5
Pollen-like mesoporous silica nanoparticles facilitate macrophage-mediated anti-inflammatory response via physical contact cues in the osteoimmune microenvironment.花粉样介孔二氧化硅纳米颗粒通过骨免疫微环境中的物理接触信号促进巨噬细胞介导的抗炎反应。
Acta Biomater. 2025 May 1;197:339-356. doi: 10.1016/j.actbio.2025.03.014. Epub 2025 Mar 8.
6
Concanavalin A-targeted mesoporous silica nanoparticles for infection treatment.靶向伴刀豆球蛋白 A 的介孔二氧化硅纳米颗粒用于感染治疗。
Acta Biomater. 2019 Sep 15;96:547-556. doi: 10.1016/j.actbio.2019.07.001. Epub 2019 Jul 3.
7
Hybrid mesoporous silica nanospheres modified by poly (NIPAM-co-AA) for drug delivery.聚(NIPAM-co-AA)改性的杂化介孔硅纳米球用于药物传递。
Nanotechnology. 2019 Aug 30;30(35):355604. doi: 10.1088/1361-6528/ab209d. Epub 2019 May 9.
8
Titania coating of mesoporous silica nanoparticles for improved biocompatibility and drug release within blood vessels.介孔硅纳米粒子的 Titania 涂层,提高了血管内的生物相容性和药物释放。
Acta Biomater. 2018 Aug;76:208-216. doi: 10.1016/j.actbio.2018.06.024. Epub 2018 Jun 20.
9
Mesoporous silica nanoparticles carrying multiple antibiotics provide enhanced synergistic effect and improved biocompatibility.载有多抗生素的介孔硅纳米颗粒提供了增强的协同作用和提高的生物相容性。
Colloids Surf B Biointerfaces. 2019 Mar 1;175:498-508. doi: 10.1016/j.colsurfb.2018.12.035. Epub 2018 Dec 13.
10
Loading of polymyxin B onto anionic mesoporous silica nanoparticles retains antibacterial activity and enhances biocompatibility.将多黏菌素 B 载入阴离子介孔硅纳米粒子中保持了其抗菌活性并提高了生物相容性。
Int J Pharm. 2018 Feb 15;537(1-2):148-161. doi: 10.1016/j.ijpharm.2017.12.039. Epub 2017 Dec 24.

引用本文的文献

1
Strategies and applications of antibacterial surface-modified biomaterials.抗菌表面改性生物材料的策略与应用
Bioact Mater. 2025 Jul 9;53:114-140. doi: 10.1016/j.bioactmat.2025.07.009. eCollection 2025 Nov.
2
Polycarboxybetaine in advanced drug delivery systems: From structure-function relationship to therapeutic applications.先进药物递送系统中的聚羧酸甜菜碱:从结构-功能关系到治疗应用
Int J Pharm X. 2025 Mar 29;9:100329. doi: 10.1016/j.ijpx.2025.100329. eCollection 2025 Jun.
3
CRISPR-Cas9 Gene Therapy: Non-Viral Delivery and Stimuli-Responsive Nanoformulations.CRISPR-Cas9基因疗法:非病毒递送与刺激响应性纳米制剂
Molecules. 2025 Jan 24;30(3):542. doi: 10.3390/molecules30030542.
4
Deciphering the Role of Inorganic Nanoparticles' Surface Functionalization on Biohybrid Microbial Photoelectrodes.解析无机纳米粒子表面功能化在生物杂化微生物光电中的作用。
ACS Appl Mater Interfaces. 2024 Oct 30;16(43):58598-58608. doi: 10.1021/acsami.4c12070. Epub 2024 Oct 20.
5
Exploring the influence of silicon oxide microchips shape on cellular uptake using imaging flow cytometry.利用成像流式细胞术研究氧化硅微芯片形状对细胞摄取的影响。
Mikrochim Acta. 2024 Aug 21;191(9):554. doi: 10.1007/s00604-024-06631-7.
6
Spearheading a new era in complex colloid synthesis with TPM and other silanes.以TPM和其他硅烷引领复杂胶体合成的新时代。
Nat Rev Chem. 2024 Jun;8(6):433-453. doi: 10.1038/s41570-024-00603-4. Epub 2024 May 13.
7
One-pot, degradable, silica nanocarriers with encapsulated oligonucleotides for mitochondrial specific targeting.用于线粒体特异性靶向的一锅法可降解二氧化硅纳米载体,其包封有寡核苷酸。
Discov Nano. 2023 Dec 21;18(1):161. doi: 10.1186/s11671-023-03926-1.
8
Antibiofilm activity of mesoporous silica nanoparticles against the biofilm associated infections.介孔二氧化硅纳米颗粒对生物膜相关感染的抗生物膜活性。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun;397(6):3617-3633. doi: 10.1007/s00210-023-02872-0. Epub 2023 Dec 5.
9
Mesoporous silica nanoparticles with dual-targeting agricultural sources for enhanced cancer treatment tritherapy.具有双重靶向农业来源的介孔二氧化硅纳米颗粒用于增强癌症三联疗法治疗
RSC Adv. 2023 Jun 23;13(28):19079-19090. doi: 10.1039/d3ra02068a. eCollection 2023 Jun 22.
10
Achievements in Mesoporous Bioactive Glasses for Biomedical Applications.用于生物医学应用的介孔生物活性玻璃的研究成果
Pharmaceutics. 2022 Nov 29;14(12):2636. doi: 10.3390/pharmaceutics14122636.

本文引用的文献

1
A novel zwitterionic bioceramic with dual antibacterial capability.一种具有双重抗菌能力的新型两性离子生物陶瓷。
J Mater Chem B. 2014 Sep 14;2(34):5639-5651. doi: 10.1039/c4tb00690a. Epub 2014 Jul 24.
2
Design and preparation of biocompatible zwitterionic hydroxyapatite.生物相容性两性离子羟基磷灰石的设计与制备
J Mater Chem B. 2013 Mar 21;1(11):1595-1606. doi: 10.1039/c3tb00122a. Epub 2013 Feb 1.
3
Molecular Design of Zwitterionic Polymer Interfaces: Searching for the Difference.两性离子聚合物界面的分子设计:探寻差异
Langmuir. 2019 Feb 5;35(5):1056-1071. doi: 10.1021/acs.langmuir.8b01789. Epub 2018 Jul 26.
4
Mesoporous silica nanoparticles for drug and gene delivery.用于药物和基因递送的介孔二氧化硅纳米颗粒。
Acta Pharm Sin B. 2018 Mar;8(2):165-177. doi: 10.1016/j.apsb.2018.01.007. Epub 2018 Feb 12.
5
Mesoporous silica nanoparticles decorated with polycationic dendrimers for infection treatment.介孔硅纳米粒子用阳离子树状聚合物进行修饰,用于感染治疗。
Acta Biomater. 2018 Mar 1;68:261-271. doi: 10.1016/j.actbio.2017.12.041. Epub 2018 Jan 5.
6
Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights.介孔二氧化硅纳米颗粒用于药物传递:当前的见解。
Molecules. 2017 Dec 25;23(1):47. doi: 10.3390/molecules23010047.
7
ImageJ2: ImageJ for the next generation of scientific image data.ImageJ2:面向下一代科学图像数据的ImageJ。
BMC Bioinformatics. 2017 Nov 29;18(1):529. doi: 10.1186/s12859-017-1934-z.
8
Lysine-Grafted MCM-41 Silica as an Antibacterial Biomaterial.赖氨酸接枝的MCM-41二氧化硅作为抗菌生物材料。
Bioengineering (Basel). 2017 Sep 26;4(4):80. doi: 10.3390/bioengineering4040080.
9
Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?到2050年,每年会有1000万人死于抗微生物药物耐药性吗?
PLoS Med. 2016 Nov 29;13(11):e1002184. doi: 10.1371/journal.pmed.1002184. eCollection 2016 Nov.
10
3D scaffold with effective multidrug sequential release against bacteria biofilm.具有有效多药序贯释放功能以对抗细菌生物膜的3D支架。
Acta Biomater. 2017 Feb;49:113-126. doi: 10.1016/j.actbio.2016.11.028. Epub 2016 Nov 11.